Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy

Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy

Indiana University School of Medicine cancer researchers have identified a potential way to use existing, accessible drugs to combat juvenile myelomonocytic leukemia (JMML) by targeting a specific inflammatory pathway. The findings, published in the journal Blood, open the door to more effective treatment options for this rare and aggressive childhood blood cancer, especially for high-risk pediatric patients who currently face limited options.